Immunofluorescence analysis of negative-enriched CTCs from HCC patients with antibodies against ASGPR and CPS1 or GPC3 showed high sensitivity and specificity for detecting CTCs and could provide relevant prognostic information [18,74]. This evidence concerns the gene ASGR1 and hepatocellular carcinoma.